Beneficient (NASDAQ:BENF – Free Report) – Investment analysts at Sidoti Csr issued their Q3 2025 earnings estimates for shares of Beneficient in a note issued to investors on Thursday, January 9th. Sidoti Csr analyst B. Mccarthy forecasts that the company will earn ($0.38) per share for the quarter. The consensus estimate for Beneficient’s current full-year earnings is ($2.02) per share. Sidoti Csr also issued estimates for Beneficient’s Q4 2025 earnings at ($0.44) EPS, FY2025 earnings at ($2.38) EPS, Q1 2026 earnings at ($0.27) EPS, Q2 2026 earnings at ($0.22) EPS, Q3 2026 earnings at $0.18 EPS, Q4 2026 earnings at $0.32 EPS, FY2026 earnings at $0.15 EPS and FY2027 earnings at $1.30 EPS.
Beneficient Trading Down 6.4 %
BENF stock opened at $0.68 on Monday. Beneficient has a 52-week low of $0.60 and a 52-week high of $35.06. The business has a 50-day simple moving average of $0.89 and a two-hundred day simple moving average of $1.70.
Institutional Investors Weigh In On Beneficient
Insider Activity at Beneficient
In other news, Director Peter T. Cangany, Jr. purchased 75,000 shares of the company’s stock in a transaction that occurred on Tuesday, November 19th. The shares were bought at an average cost of $0.93 per share, with a total value of $69,750.00. Following the completion of the transaction, the director now directly owns 300,000 shares of the company’s stock, valued at approximately $279,000. This trade represents a 33.33 % increase in their ownership of the stock. The acquisition was disclosed in a legal filing with the SEC, which can be accessed through this link. Insiders have sold a total of 17,729 shares of company stock valued at $14,290 over the last 90 days. Insiders own 13.69% of the company’s stock.
Beneficient Company Profile
Beneficient, a technology-enabled financial services company, provides liquidity solutions and related trustee, custody and trust administrative services to participants in the alternative asset industry in the United States. It operates through Ben Liquidity, Ben Custody, and Customer ExAlt Trusts segments.
Featured Stories
- Five stocks we like better than Beneficient
- The Top 3 Healthcare Dividend Stocks to Buy and Hold
- ServiceTitan Made Waves in Its IPO, But Is the Stock a Buy?
- How to Calculate Return on Investment (ROI)
- Netflix: Is This the Perfect Time to Buy a Streaming Powerhouse?
- Roth IRA Calculator: Calculate Your Potential Returns
- Goldman Sachs Unveils 3 Massive Opportunities for 2025 Investors
Receive News & Ratings for Beneficient Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Beneficient and related companies with MarketBeat.com's FREE daily email newsletter.